Search

Your search keyword '"SPADARO, Giuseppe"' showing total 78 results

Search Constraints

Start Over You searched for: Author "SPADARO, Giuseppe" Remove constraint Author: "SPADARO, Giuseppe" Database Academic Search Index Remove constraint Database: Academic Search Index
78 results on '"SPADARO, Giuseppe"'

Search Results

1. Basophil degranulation in response to IgE ligation is controlled by a distinctive circadian clock in asthma.

2. Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.

3. Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy.

5. Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab.

6. Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N‐acylethanolamines in patients with hereditary angioedema due to FXII mutation.

7. Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.

8. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.

9. Corrigendum to “Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia” [Int. Immunopharmacol. 44 (2017) 38–42].

10. High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study.

11. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review.

12. Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.

13. Is there a role for microbiome-based approach in common variable immunodeficiency?

14. Could it be hereditary angioedema?—Perspectives from different medical specialties.

15. BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.

16. Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.

17. Gender dimorphism in IgA subclasses in T2-high asthma.

18. A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us?

19. Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study.

20. Biologics and airway remodeling in severe asthma.

21. Epigenetics: An opportunity to shape innate and adaptive immune responses.

22. Effect of hydrothermal ageing on the thermal and delamination fracture behaviour of CFRP composites.

23. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.

24. Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma.

25. Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel.

26. Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis.

27. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.

28. Mode I fracture toughness behavior of hydro-thermally aged carbon fibre reinforced DGEBA-HHPA-PES systems.

29. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis.

30. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.

31. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study.

32. Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients.

34. Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.

35. Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies.

36. Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019.

37. Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study.

38. Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.

39. Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency?

40. Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.

41. Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS).

42. Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the Literature.

43. Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.

44. Water diffusion and swelling stresses in ionizing radiation cured epoxy matrices.

45. Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels.

46. Water diffusion and swelling stresses in highly crosslinked epoxy matrices.

47. High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study.

48. Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.

49. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study.

50. In-situ polymerization of polyaniline in radiation functionalized polypropylene films.

Catalog

Books, media, physical & digital resources